Skip to main content
Tech.euFundingExplorerBeta

Neuroplast

Neuro-regenerative personalized medicine is one of the most promising therapies, which needs dedicated uniform standards and regulations.

Total raised
€14M
€14,000,000
Funding rounds
2
Investors
4
distinct backers
Active since
2020-02
latest 2021-11

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood20
base rate 48% for Series B
  • Dormant (no round in 3+ cohort gaps)
  • Up-round momentum
  • Low backer re-investment
Exit likelihood13
base rate 12% (2+ rounds)
  • 12y since founding

Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

2 rounds

Similar companies

same sector or country